Neptinib is a quinazoline-based compound with a molecular structure featuring an amide, ether, and halogen substituents. It is recognized as an active pharmaceutical ingredient used in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2085843-51-0
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide
pharmaceutical raw material
(+)-vestitol
pharmaceutical raw material
Testosterone benzoate
pharmaceutical raw material
Finerenone metabolite M3
pharmaceutical raw material
N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-2-ethanamine
pharmaceutical raw material
Erlotinib hydrochloride
pharmaceutical raw material
Erlotinib
pharmaceutical raw material
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline
pharmaceutical intermediate
(E)-N-[4-(3-chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
RTAAZCCTCLCXHX-AATRIKPKSA-N
CCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN(C)C